BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 112 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $962,000 | -60.4% | 310,346 | -53.9% | 0.00% | -100.0% |
| Q3 2021 | $2,431,000 | +306.5% | 673,488 | +302.9% | 0.00% | – |
| Q2 2021 | $598,000 | -61.7% | 167,153 | -58.2% | 0.00% | – |
| Q1 2021 | $1,563,000 | -9.0% | 399,936 | -2.2% | 0.00% | – |
| Q4 2020 | $1,717,000 | +18.2% | 409,004 | +5.0% | 0.00% | – |
| Q3 2020 | $1,453,000 | -15.6% | 389,684 | -1.3% | 0.00% | -100.0% |
| Q2 2020 | $1,722,000 | +51.5% | 394,645 | +31.4% | 0.00% | – |
| Q1 2020 | $1,137,000 | +3.7% | 300,305 | +73.3% | 0.00% | – |
| Q4 2019 | $1,096,000 | +89.0% | 173,284 | +26.0% | 0.00% | – |
| Q3 2019 | $580,000 | +48.3% | 137,581 | +63.4% | 0.00% | – |
| Q2 2019 | $391,000 | +34.8% | 84,186 | +54.4% | 0.00% | – |
| Q1 2019 | $290,000 | +9.0% | 54,507 | -24.0% | 0.00% | – |
| Q4 2018 | $266,000 | -19.6% | 71,695 | -39.3% | 0.00% | – |
| Q3 2018 | $331,000 | +110.8% | 118,060 | +121.7% | 0.00% | – |
| Q2 2018 | $157,000 | +4.0% | 53,257 | -21.0% | 0.00% | – |
| Q1 2018 | $151,000 | -23.7% | 67,413 | +0.5% | 0.00% | – |
| Q4 2017 | $198,000 | +88.6% | 67,081 | +88.9% | 0.00% | – |
| Q3 2017 | $105,000 | +150.0% | 35,506 | +138.2% | 0.00% | – |
| Q2 2017 | $42,000 | +50.0% | 14,907 | 0.0% | 0.00% | – |
| Q1 2017 | $28,000 | +1300.0% | 14,907 | +1040.6% | 0.00% | – |
| Q4 2016 | $2,000 | -92.0% | 1,307 | -85.8% | 0.00% | – |
| Q3 2016 | $25,000 | +25.0% | 9,230 | +11.1% | 0.00% | – |
| Q2 2016 | $20,000 | -79.4% | 8,307 | -72.3% | 0.00% | – |
| Q1 2016 | $97,000 | -32.2% | 30,011 | +0.4% | 0.00% | – |
| Q4 2015 | $143,000 | -5.9% | 29,892 | +9.0% | 0.00% | – |
| Q3 2015 | $152,000 | -61.6% | 27,432 | -44.9% | 0.00% | – |
| Q2 2015 | $396,000 | -98.7% | 49,766 | -98.2% | 0.00% | -100.0% |
| Q1 2015 | $29,358,000 | +112.5% | 2,796,202 | +143.2% | 0.01% | +20.0% |
| Q4 2014 | $13,818,000 | +45.1% | 1,149,645 | +106.3% | 0.01% | +25.0% |
| Q3 2014 | $9,524,000 | +3363.3% | 557,284 | +2349.5% | 0.00% | – |
| Q2 2014 | $275,000 | +1347.4% | 22,751 | +934.1% | 0.00% | – |
| Q1 2014 | $19,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |